hiPSC-derived cardiomyocytes

· HELP Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hiPSC-derived cardiomyocytes, covering 2023-11-22 to 2023-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Treating Heart Failure With hiPSC-CMs [Phase 1, Phase 2]